• Current

Genopis, Inc.
homepage |
Genopis, is a newly established contract manufacturing organization (CMO) for developing & manufacturing gene therapy products. Genopis is established by a joint venture partnership between Medivate & a Korean biotech company, Viromed Co., Ltd. (public) which has multiple ongoing clinical programs, among which the PhIII trial for diabetic peripheral neuropathy (DPN) is the lead program. Genopis will begin manufacturing Viromed’s PhIII (DPN) products in 2019. 

WindMIL Therapeutics
homepage |
WindMIL is a US Biotech company developing ground-breaking immuno-oncology therapeutics employing unprecedented technologies of harnessing the power of bone marrow derived T cells to treat both blood and solid tumors. WindMIL utilizes the unique property of bone marrow, which is a natural reservoir of memory T cells, to develop highly efficient, cancer-fighting warriors. 

Cognate BioServices, Inc.
homepage |
Cognate BioServices, Inc. is one of four well established contract manufacturing organizations (CMO) in the United States, with expertise in the clinical and commercial development, and manufacturing of cell therapies. Cognate is the only CMO to date capable of commercial scale manufacturing of cell therapies, with global No1. Capacity. Cognate has unparalleled experience in providing personalized immuno-oncology products in the largest PhIII cell- therapy clinical trial. With the recent FDA app

WCCT Global, Inc.
homepage |
WCCT Global is a multi-site, full service pharmaceutical contract research organization (CRO) of outsourced early drug development and late phase CRO services to the pharmaceutical, biotechnology and medical device industries. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Renal, and Vaccines. 

맨처음이전 1 다음맨뒤로